Sen. Ron Wyden (D-OR) (Francis Chung/E&E News/POLITICO via AP Images)
October 1, 2024 03:27 PM EDTUpdated October 2, 07:42 AM
FDA+
Law

Up­dat­ed: Sen­a­tors ques­tion FDA and FTC over patent and PBM re­forms

Zachary Brennan

Senior Editor

Sen­a­tors may be back in their dis­tricts gear­ing up for next month’s elec­tions, but that isn’t stop­ping them from ques­tion­ing both the FDA and Fed­er­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times